Featured News
Melanoma and Skin Cancer Trials has been chosen by the Australian Livestock and Property Agents Association (ALPA) as its 2024 charity.
As a young doctor, Prof Mark Shackleton was focused on becoming a neurologist, until one day, he found himself on an oncology ward. Witnessing the profound challenges faced by cancer patients left a deep impact on him, igniting a passion for melanoma research.
When John was offered a place on the CHARLI trial to treat his stage IV melanoma, he didn't hesitate, especially as he could access the treatment near his home in regional Victoria.
When Allen Schnitzerling was diagnosed with Merkel cell carcinoma, his prognosis was dire. But after putting his faith in his doctors and their “special soup”, as he affectionally calls it, Allen is now planning adventurous holidays with his wife.
When Lisa, Jenny and Vikki immigrated to Australia in their younger years, they had no idea that the outdoor lifestyle they embraced would lead to a melanoma diagnosis later in life.
Stuart is a participant in the Melanoma Margins Trial
Melanoma and Skin Cancer Trials and the Victorian Heart Institute are leading an Australian-first trial to determine if a common cholesterol medication can reduce the risk of heart attacks in melanoma patients treated with cancer therapy.
A $110,000 donation to a new trial treating melanoma brain metastases will help open additional research sites around Australia, offering hope to patients, like Peter Wilson, who have melanoma that has spread to the brain.
MASC Trials, MSCAN and BlazeAid have partnered to deliver sun safety educational videos for BlazeAid volunteers so they know how to protect their skin during frontline disaster response work.
John, who has Merkel cell carcinoma, is participating in the I-MAT trial.